Oracefal en es it fr

Oracefal Brand names, Oracefal Analogs

Oracefal Brand Names Mixture

  • None

Oracefal Chemical_Formula


Oracefal RX_link


Oracefal fda sheet

Oracefal msds (material safety sheet)

Oracefal Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Oracefal Molecular Weight

363.389 g/mol

Oracefal Melting Point


Oracefal H2O Solubility

1110 mg/L

Oracefal State


Oracefal LogP


Oracefal Dosage Forms

Capsule; Tablet; Oral liquid

Oracefal Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Oracefal Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Oracefal Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Oracefal side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Oracefal Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Oracefal Organisms Affected

Enteric bacteria and other eubacteria